Synlogic Inc

NASDAQ:SYBX   3:59:50 PM EDT
3.13
-0.05 (-1.57%)
Products, Strategic Combinations

Synlogic Enters Research Collaboration With Roche For Development Of Novel Therapy

Published: 06/17/2021 11:38 GMT
Synlogic Inc (SYBX) - Synlogic Enters Research Collaboration With Roche for Development of Novel Therapy to Treat Inflammatory Bowel Disease.
Synlogic Inc - Entered Into a Research Collaboration Agreement With Roche.
Synlogic Inc - Synlogic and Roche Will Collaborate to Develop a Synthetic Biotic Medicine Addressing an Undisclosed Novel Target in Ibd.
Synlogic Inc - at End of Research Period, Roche Will Have Exclusive Option to Enter Agreement for Further Development and Commercialization of Program.